April Abele Isaacson has 25 years of experience as a trial lawyer and is a registered United States patent attorney. Her practice focuses on pharmaceutical, biotechnology, and chemical patent litigation, particularly Hatch-Waxman cases on behalf of drug innovators. April has tried cases in several federal district courts throughout the United States, as well as appeals before the Federal Circuit, representing both plaintiffs and defendants. April also provides counseling on patent and related regulatory issues faced by the biopharma industry, including patent portfolio strategy, litigation preparation and strategy, licensing, patent term extension strategy, and Orange Book patent listing and Use Code strategy, and provides opinions on issues of patentability/validity, freedom-to-operate, and loss of exclusivity.
April previously served for nearly five years as in-house counsel at a public specialty pharmaceutical company where she provided broad intellectual property and regulatory strategic counseling during all stages of product development and managed numerous Hatch-Waxman litigations. She also served as a partner at a major international law firm and at a predecessor firm to Kilpatrick Townsend.
April began her legal career as a U.S. Navy JAG Corps prosecutor where she won several high profile jury cases and earned multiple achievement medals and letters of commendation for superior service and leadership. Prior to attending law school, she was an HIV/AIDS research scientist at Boston Children’s Hospital.
Representing a pharmaceutical company in Hatch-Waxman litigations concerning a drug for treatment of opioid-induced constipation.
Counseling a pharmaceutical company in preparation for Hatch-Waxman litigations concerning a drug for early onset childhood epilepsy.
Counseling a pharmaceutical company in preparation for adversarial patent actions with a non-practicing patent holder.
*Counseled a pre-commercial biopharmaceutical company on portfolio strategy and development partnerships.
*Represented a pharmaceutical company as in-house counsel in Hatch-Waxman litigation concerning a nasal spray product.
*Represented a pharmaceutical company as in-house counsel in Hatch-Waxman litigation concerning a drug for Parkinson's disease.
*Represented a pharmaceutical company in Hatch-Waxman litigation concerning a drug for treating diarrhea and irritable bowel syndrome.
*Represented a leading agricultural chemical company and a specialty pest control chemical manufacturer in a patent infringement action concerning patents relating to the pesticide fipronil.
*Represented a pharmaceutical company in a Hatch-Waxman litigation concerning a synthetic vitamin drug.
*Represented a manufacturer of biological and pharmaceutical products for animals in patent infringement litigation actions brought by an animal health company on patents related to vaccines, vaccine components, and recombinant DNA techniques for making vaccines.
*Experience gained by attorney prior to joining Kilpatrick Townsend
Insights View All
Mount Holyoke College A.B. Biological Sciences, cum laude
The University of Chicago M.S. Pharmacological and Physiological Sciences, Committee on Cellular and Molecular Physiology
Vanderbilt University School of Law J.D.
District of Columbia (1997)
U.S. District Court for the Eastern District of Michigan
MEMO|Medicine & Molecules, The Kilpatrick Townsend Biopharma Industry Blog, Co-Editor-in-Chief
U.S. Navy, Prosecutor/Officer-in-Charge, Criminal Defense and Legal Assistance Attorney (1995-1999 Active Duty; 1999-2003 Reserve)
CalVet Women Veterans Division, Member
San Francisco Intellectual Property Law Association, Member
American Intellectual Property Law Association, Member
Federal Circuit Bar Association, Member
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.